Biotech · Public company · Ashburn, VA, US

Quoin Pharmaceuticals Ltd.

Ticker QNRX · SEC CIK 0001671502

Track this companyFree. Adds Quoin Pharmaceuticals Ltd. to your Dealase workspace and tells you when its record changes.

Clinical trials44 recruiting or active

Pipeline programs6From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline6

QRX003Phase 3 · Netherton SyndromeClinicalTrials.gov · fetched Nov 12, 2026
QRX003-2% LotionPhase 3 · Netherton SyndromeClinicalTrials.gov · fetched Nov 12, 2026
QRX003-4% Lotion BIDPhase 3 · Netherton SyndromeClinicalTrials.gov · fetched Nov 12, 2026
QRX003-4% Lotion QAMPhase 3 · Netherton SyndromeClinicalTrials.gov · fetched Nov 12, 2026
QRX003, 4% LotionPhase 3 · Netherton SyndromeClinicalTrials.gov · fetched Nov 12, 2026
VehiclePhase 3 · Netherton SyndromeClinicalTrials.gov · fetched Nov 12, 2026

Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromePHASE2_PHASE3 · RECRUITING · started Mar 19, 2026ClinicalTrials.gov NCT07538583 · fetched Nov 12, 2026
Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromePHASE2_PHASE3 · RECRUITING · started Oct 6, 2025ClinicalTrials.gov NCT06953466 · fetched Nov 12, 2026
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton SyndromePHASE2_PHASE3 · RECRUITING · started Mar 14, 2023ClinicalTrials.gov NCT05789056 · fetched Nov 12, 2026
Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton SyndromePHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Jun 23, 2022ClinicalTrials.gov NCT05521438 · fetched Nov 12, 2026